On the recordSeptember 18, 2014
Do you believe that we need to further incentivize new drug and diagnostic development if we are to appropriately address the issue of antibiotic resistance, and if so, what would you recommend?
Source
congress.govEditor's note · Context
Pitts questions the need for incentives in drug development for antibiotic resistance.
Share
More from Joe Pitts
Jul 6, 2016
So, moving forward, the committee welcomes feedback on how we can improve care for children with medical complexity without disrupting the successful approaches already in place.
Jul 11, 2016
One in five trauma deaths may be preventable or, in other words, about 30,000 people might be saved every year.
Sep 13, 2016
Today's hearing is especially timely as we learned startling news over the summer, confirming our worst fears, that the some of the most significant health insurers--UnitedHealth, Aetna, Humana--are opting out of Obamacare's health…
Other voices in this conversation
